This same structural modification also provides some protection against degradation in storage compared to unmodified peptides
1 Since the study is ongoing, results from the weight-maintenance phase are not yet available, along with the safety and efficacy of trevogrumab and garetosmab
Evidence type: Human RCT | Observational | Animal | In vitro | Regulatory Mechanism of Action AOD-9604 mimics the fat-metabolizing region of growth hormone
Advancements in drug delivery systems, such as oral GLP-1 agonists and once-weekly injections, aim to improve patient adherence and convenience, enhancing the overall management of chronic conditions like diabetes and obesity
Market share erosion and gain analysis indicates that established therapies may face declining use as GLP-1 drugs capture increasing market share due to superior clinical outcomes
This mechanistic separation means the two drug classes do not typically compete for the same metabolic enzymes or receptor sites